SCN2A and epilepsy: These compounds were docked against identified epilepsy targets– Voltage-gated sodium channel subunit α2 (Nav1.2);GABA receptor α1-β1; and Voltage-gated calcium channel α1G (Cav3.1)using Carbamazepine, Clonazepam, and Pregabalin as standard drugs, respectively.